Craig Gibeau

Statistics

Publications

Citations

185

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Miami University

Craig Gibeau is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2004–2022

Publications

The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer

Ryan V. Quiroz, Michael H. Reutershan, Sebastian E. Schneider et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors

Vladimir Simov, Sujal V. Deshmukh, Christopher J. Dinsmore et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation

G. Smith, Michael D. Altman, Brian M. Andresen et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Total synthesis of two novel brominated acetylenic diols (+)-diplyne C and E: stereoselective construction of the (E)-1-bromo-1-alkene

Benjamin W. Gung, Craig Gibeau, Amanda Jones · Tetrahedron Asymmetry · 2005 · 24 citations

Natural Sciences, Chemistry, Organic Chemistry +7

First total synthesis of the brominated polyacetylenes (+)-diplyne A and D: proof of absolute configuration

Benjamin W. Gung, Craig Gibeau, Amanda Jones · Tetrahedron Asymmetry · 2004 · 21 citations

Natural Sciences, Chemistry, Organic Chemistry +8

1–5 of 8